Global search

Find data and evidence

Type at least 2 characters. Use arrow keys to review and Enter to open.

Disease overview

Bacterial

Toxic shock syndrome

中毒性休克综合征

Follow this disease Compare countries
Evidence-backed information EN 3/7 applicable sections · ZH 3/7 applicable sections Updated Oct 23, 2026

Toxic shock syndrome is a rare, life-threatening, toxin-mediated illness most often caused by toxin-producing Staphylococcus aureus or Streptococcus pyogenes [1][2][3]. It manifests acutely with multi-system involvement and carries substantial morbidity and mortality, yet is considered underdiagnosed among patients with staphylococcal or group A streptococcal infection who present with shock [1][2][3]. Scientific literature is limited largely to observational studies and case reports because of the disease's low incidence [1].

Read the full clinical and epidemiological profile 4
Syndrome or outcome definition

Toxic shock syndrome is an acute, multi-system, toxin-mediated disease representing the most fulminant expression of illness caused by toxin-producing strains of Staphylococcus aureus or Streptococcus pyogenes [1][2][3]. Bacterial superantigenic exotoxins drive unconventional lymphocyte activation and a cytokine avalanche that bypasses normal antigen processing, leading to rapid shock and organ dysfunction [1][2][3].

Clinical criteria and consequences

The syndrome is characterized by rapid shock, multiple organ failure, and potential death driven by superantigen-mediated immune activation [1][2][3]. Staphylococcal forms may be menstrual or nonmenstrual, whereas streptococcal toxic shock is frequently associated with severe group A streptococcal infection and often a necrotizing soft tissue infection [1]. Disseminated intravascular coagulation and tissue damage may arise from the cytokine cascade [2].

Occurrence and burden

Toxic shock syndrome is a rare disease with low incidence that has been described principally through observational studies, clinical cases, and in vitro data [1].

References
  1. 1 Atchade E et al. Toxic Shock Syndrome: A Literature Review. Antibiotics (Basel). 2024 Jan 18. PMID: 38247655. doi: 10.3390/antibiotics13010096. PubMed: https://pubmed.ncbi.nlm.nih.gov/38247655/
  2. 2 Lappin E et al. Gram-positive toxic shock syndromes. Lancet Infect Dis. 2009 May. PMID: 19393958. doi: 10.1016/S1473-3099(09)70066-0. PubMed: https://pubmed.ncbi.nlm.nih.gov/19393958/
  3. 3 Hansen NS et al. [Toxic shock syndrome]. Ugeskr Laeger. 2020 May 11. PMID: 32400378. PubMed: https://pubmed.ncbi.nlm.nih.gov/32400378/
Coding Register
ICD-10
ICD-11
Data coverage

Loading current data…

Country surveillance trends

Choose a country, source, and measure. Each line retains its published reporting period and definition.

Loading data…

Coverage

Reporting countries and regions

The map shows reporting coverage. Select a measure or open a shaded location to inspect its data.

Loading current data…

Surveillance pattern

Year × month seasonality by country

Review one country’s published monthly values by year. Empty cells indicate values the source did not publish.

Research Radar

Recent related research

View all research →

Showing 5 of 10 related publications.

Literature links are provided for discovery and do not alter or validate the surveillance series above.

Loading official alerts…

Downloads and methods

Choose a time range and download CSV, JSON or XLSX files.

Partitioned public data

Choose a time range and format

Download archives have their own release date and may differ from the live curves.